Snyder Capital Management L P
Snyder Capital Management L.P. is an independent, San Francisco-based investment advisory and asset management firm, founded in 1984. The firm specializes in managing assets for institutional clients, family offices, and high-net-worth individuals. With approximately 17 employees, Snyder Capital Management offers investment strategies and portfolio management with a focus on sustainable, long-term growth. The firm has been independently owned since January 2016 and continues to serve a diverse range of investors.
Investment Strategy
Snyder Capital Management L.P. takes an active management approach, focusing on fundamental research and portfolio diversification across equities and other asset classes. The firm emphasizes sustainable long-term growth, risk management, and capital preservation in its investment philosophy, constructing portfolios tailored to the objectives of institutional and high-net-worth clients. Top holdings often include mid-to-large cap companies chosen for strong fundamentals and growth prospects. The firm continually assesses market opportunities and adjusts allocations to optimize portfolio performance.
Latest 13F Filing Activity
Snyder Capital Management L P filed their most recent 13F report on Jun 30, 2025 disclosing 66 equity positions with a total 13F market value of $5B. The fund increased holdings in BWX Technologies Inc., Amphenol Corp. CL A, Dolby Laboratories Inc. CL A among other positions. Snyder Capital Management L P reduced exposure to Halozyme Therapeutics Inc., Iqvia Holdings Inc., Fti Consulting Inc. among others.
Top Holdings
Equity Positions (66)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
C CLH | CLEAN HARBORS INC | 5.24% | $246.2M | 1,064,866 | $66.00 | $231.18 | +$26.4M |
B BWXT | BWX TECHNOLOGIES INC | 5.04% | $236.8M | 1,643,493 | $53.22 | $144.06 | +$56.9M |
E ENTG | ENTEGRIS INC | 3.77% | $177.3M | 2,198,403 | $49.71 | $80.65 | -$13.3M |
H HALO | HALOZYME THERAPEUTICS INC | 3.76% | $176.7M | 3,397,697 | $25.94 | $52.02 | -$57.7M |
U UGI | UGI CORP | 3.73% | $175.1M | 4,807,958 | $29.62 | $36.42 | +$8.6M |
Industry Allocation
Investment Team (4)
| Name | Role | Location | |
|---|---|---|---|
M Michael Ellis | Research Analyst | San Francisco, CA , United States | |
| Research Analyst | San Francisco, CA , United States | ||
 | Portfolio Manager | San Francisco, CA , United States | |
S Scott Molinaroli | Portfolio Manager | San Francisco, CA , United States |